Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

Human Menopausal Gonadotrophin

    • Product Name Human Menopausal Gonadotrophin
    • Alias Menotropin
    • Einecs 248-829-2
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    360741

    generic_name Human Menopausal Gonadotrophin
    abbreviation hMG
    source Urine of postmenopausal women
    composition FSH and LH (Follicle-stimulating hormone and Luteinizing hormone)
    route_of_administration Intramuscular injection
    indication Treatment of infertility
    mechanism_of_action Stimulates ovarian follicle growth and ovulation in females; stimulates spermatogenesis in males
    contraindications Ovarian, testicular, or prostate tumors
    common_brand_names Menopur, Repronex, Pergonal
    common_side_effects Abdominal pain, bloating, injection site reactions
    ATC_code G03GA02
    storage_conditions Refrigerate between 2°C and 8°C
    pregnancy_category X
    legal_status Prescription only
    molecular_weight Varies (glycoprotein complex)

    As an accredited Human Menopausal Gonadotrophin factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing The packaging contains 75 IU Human Menopausal Gonadotrophin, sealed in a clear glass vial with a white flip-off cap and labeled instructions.
    Shipping Human Menopausal Gonadotrophin (hMG) is shipped in temperature-controlled packaging, typically requiring refrigeration (2–8°C) to maintain stability. It is securely packed to prevent damage and ensure product integrity. All shipments comply with regulatory guidelines for pharmaceutical products, including proper labeling and documentation for safe and traceable delivery.
    Storage Human Menopausal Gonadotrophin (hMG) should be stored in a refrigerator at 2°C to 8°C (36°F to 46°F). Protect it from light and do not freeze. If storage outside the refrigerator is necessary, keep it below 25°C (77°F) for a limited time as specified by the manufacturer. Always keep the medication in its original packaging until use.
    Application of Human Menopausal Gonadotrophin
    Purity 99%: Human Menopausal Gonadotrophin with 99% purity is used in controlled ovarian hyperstimulation protocols, where it ensures consistent follicular development and increased oocyte yield. Stability at 2-8°C: Human Menopausal Gonadotrophin with stability at 2-8°C is used in fertility clinics, where it maintains biological activity during storage and transportation. Biological Activity ≥ 75 IU/vial: Human Menopausal Gonadotrophin with biological activity ≥ 75 IU/vial is used in assisted reproductive technology procedures, where it induces effective ovulation. Endotoxin Level ≤ 0.5 EU/mg: Human Menopausal Gonadotrophin with endotoxin level ≤ 0.5 EU/mg is used in in vitro fertilization treatments, where it minimizes risk of pyrogenic reactions. Lyophilized Form: Human Menopausal Gonadotrophin in lyophilized form is used in hospital pharmacy compounding, where it offers extended shelf life and ease of reconstitution. Molecular Weight 30-40 kDa: Human Menopausal Gonadotrophin with molecular weight 30-40 kDa is used in hormone replacement therapies, where it guarantees specific receptor binding and therapeutic efficacy. Specific Activity > 10,000 IU/mg: Human Menopausal Gonadotrophin with specific activity > 10,000 IU/mg is used in controlled clinical fertilization protocols, where it supports efficient hormonal stimulation. Reconstitution Volume 1 mL: Human Menopausal Gonadotrophin with reconstitution volume 1 mL is used in individualized dosing regimens, where it facilitates accurate patient-specific administration. pH Range 6.5-7.5: Human Menopausal Gonadotrophin with pH range 6.5-7.5 is used in injectable infertility medications, where it enhances formulation compatibility and patient tolerance. Residual Moisture < 1.5%: Human Menopausal Gonadotrophin with residual moisture < 1.5% is used in long-term pharmaceutical storage, where it prevents degradation and maintains potency.
    Free Quote

    Competitive Human Menopausal Gonadotrophin prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Bringing Clarity to Human Menopausal Gonadotrophin: What Sets This Therapy Apart

    Understanding the Placement of Human Menopausal Gonadotrophin in Modern Medicine

    Human Menopausal Gonadotrophin or HMG holds a key place in reproductive health, especially for people facing fertility issues. Having seen couples move mountains for a chance to start a family, I know where this product fits—a crossroads of science, hope, and personal struggle. HMG, a combination of follicle-stimulating hormone (FSH) and luteinizing hormone (LH), gets sourced from the urine of postmenopausal women. Years back, folks had far fewer options, and many spent months or even years chasing answers that just didn’t exist. Now, for people dealing with problems like ovulation disorders or certain male fertility challenges, HMG offers a path that wasn’t available to our parents or grandparents.

    The Unique Combination Inside Each Injection

    Every vial of HMG brings together FSH and LH in nearly balanced amounts, and that makes a real difference—no synthetic guesswork or incomplete mimicry. This balance isn’t just a technical note. It means women with anovulation or men with hypogonadotropic hypogonadism receive the biological triggers their bodies might stop producing on their own. To put it plainly, where the body’s signals are weak, HMG can boost them, supporting the cascade needed for healthy egg or sperm development.

    I’ve heard skepticism about products like HMG before. Many people wonder if it outshines newer, recombinant options. Here’s the reality: HMG comes from a natural source, derived from real human hormones, which gives some reassurance to those who are wary of synthetic treatments. Plus, having both hormones in one product avoids the need for multiple injections, which, on tough days, really matters. It’s not an abstract improvement, but a genuine relief. To those caught in the daily grind of treatment, one fewer jab is more than a technical upgrade.

    Specifications That Matter in Practice

    Vials of HMG usually contain a measured blend, often 75 IU of FSH and 75 IU of LH per ampoule, though manufacturers may offer different strengths. Here’s where it gets personal: doctors can tailor cycles without constantly worrying about shortages in one hormone or overdoing another. In some clinics, I’ve seen how this flexibility lets professionals fine-tune protocols, adjusting doses based on how each patient’s body responds.

    The stability and purity of modern HMG preparations have improved a great deal over the last few decades. Decades ago, clinicians and patients had to navigate variable results from early preparations, but today’s purification methods cut the chance of reaction or contamination. Studies, such as those published in peer-reviewed journals like Fertility and Sterility, underline how far the industry has come on that front.

    Comparing HMG With Other Gonadotrophins on the Market

    People often ask how HMG stacks up against recombinant FSH products or purified urinary FSH. On paper, recombinant options offer total consistency and no risk of viral transmission. For some, that’s important, especially when cost isn’t a major worry. Still, in parts of the world with tighter healthcare budgets, HMG often remains the go-to option because it delivers both active ingredients in a cost-effective package. This dual-action is missing from single-agent FSH options.

    Another point: the use of HMG may more closely replicate the natural hormonal environment found in early follicular development. This matters particularly in women with certain forms of ovarian dysfunction. Even some clinical guidelines note that the LH component can support follicle maturation better in a subset of patients compared to FSH-only products. Of course, not every doctor will choose HMG for every situation—treatment is deeply personal, iterative, and should always reflect the latest research.

    The Role of HMG in Assisted Reproductive Technologies

    HMG plays a strong role in both in vitro fertilization (IVF) and intrauterine insemination (IUI) cycles. I’ve seen firsthand how clinics keep HMG on hand, especially for women who either fail to respond to FSH alone or need a jump-start to produce multiple follicles. Some protocols use HMG from the beginning, while others introduce it midway to shore up LH levels. This strategic mixing of triggers can determine whether a treatment cycle succeeds or gets canceled.

    People undergoing these protocols don’t simply want numbers and percentages—they want hope, and HMG has delivered that for countless families. For many women over age 35, for example, doctors may recommend HMG as a way to address the subtle aging of hormonal signals. There’s a reason its use has endured for decades, even as newer products hit the market: it works in real-world conditions, for real people.

    Handling and Administration—Voices From the Clinic

    In terms of preparation and administration, HMG arrives as a lyophilized powder, requiring careful mixing with sterile diluent before injection. The instructions seem straightforward, but anxiety can run high for people facing this the first time. Nurses often take a hands-on role, showing patients exactly how to reconstitute and measure the dose. Over the years, I’ve found that simplifying the prep and providing clear, compassionate guidance makes all the difference. Some clinics host small-group teaching, giving people a chance to practice in a low-stress setting.

    Subcutaneous injections, as recommended for most HMG preparations, mean people inject the medication into fatty tissue, typically around the abdomen. Unlike deep intramuscular shots, these cause less discomfort and carry fewer risks, such as hitting a blood vessel. Still, every patient is different—what feels manageable to one may cause nerves for another. Patience, repetition, and honest answers about what to expect seem to work better than technical explanations alone.

    Cost, Access, and Social Impact

    Costs for HMG vary by country, healthcare system, and insurance status, but the medication often comes in far below the price tag of synthetic alternatives. This has ripple effects. In areas where public funding or insurance support for fertility treatment is limited, HMG means more patients can try therapies they might otherwise never afford. It’s not just about statistics or protocols, either. I’ve spoken with couples who worked overtime, saved for years, or sought family loans simply to make one IVF cycle possible. For them, the existence of a cost-effective, reliable option is a lifeline.

    Access shapes outcomes. According to data from the World Health Organization and the European Society of Human Reproduction and Embryology, economic barriers remain a leading reason people forgo or delay fertility care. HMG helps level the playing field a bit, especially outside wealthier urban centers. Ensuring safe, affordable access to high-quality HMG—along with proper monitoring—should remain a public health priority, not just a pharmacy debate.

    Individualized Care, Not One-Size-Fits-All Treatment

    Doctors and patients alike recognize that fertility medicine defies a plug-and-play approach. The decision to use HMG or another gonadotropin isn’t just a matter of reading a pamphlet. Bloodwork, ultrasound findings, age, diagnosis, and past cycle outcomes all shape what gets prescribed. Anyone telling you there’s a single “best” medication doesn’t have enough experience with the complexity of real people’s lives.

    For men, HMG can trigger the body to restart natural testosterone and sperm production in cases where the pituitary fails to send the right signals. Success rates aren’t perfect, but they’re meaningful—especially given the limited alternatives when hypogonadotropic hypogonadism gets diagnosed. In these scenarios, HMG offers both an evidence-backed and pragmatic solution, often forming the cornerstone of long-term treatment plans.

    Weighing Benefits and Potential Side Effects

    No discussion about HMG feels complete without addressing trade-offs. Like all medications, HMG carries the potential for side effects—reactions at the injection site, mood swings, or overstimulation of the ovaries. In rare cases, ovarian hyperstimulation syndrome (OHSS) can develop. Patients and clinicians need open, ongoing discussions on these risks, especially in high-response patients or those with polycystic ovary syndrome (PCOS). It’s worth noting that close monitoring—through blood tests and ultrasounds—has dramatically cut the rate of hospitalizations related to OHSS in recent years.

    For males on HMG, some experience mild discomfort or breast tenderness as hormone levels shift. Side effects remain manageable in the hands of an experienced care team, and staying transparent about these risks lets patients make informed choices without fear or misinformation clouding their judgment.

    HMG and Advances in Assisted Reproductive Technology

    Medical science never stands still. In the last decade, newer protocols have combined recombinant and urinary-derived gonadotropins for tailored cycles, yet HMG still holds a seat at the table. In fact, many clinics now design regimens where HMG forms the backbone, particularly for patients with previous poor responses to FSH-only treatments.

    Recent studies attracted attention by suggesting that, for women with low ovarian reserve or advanced maternal age, adding or swapping to HMG has sometimes improved pregnancy rates. These gains aren’t universal, but they underscore the value of keeping a variety of treatment tools available rather than chasing a single “silver bullet” medication. Flexibility benefits both the practitioner and patient, letting science and real-world practice inform each decision together.

    The Trust Factor: Building Confidence in HMG

    As someone who has watched both successes and disappointments unfold, I believe trust in a preparation comes from experience, guidance, and a willingness to share the full story—joys, doubts, and all. Any product that repeatedly helps real people reach cherished goals deserves a place in the broader discussion, and HMG has earned that seat through decades of outcome data, real-world use, and ongoing patient stories.

    For many, the hurdle isn’t just about the clinical statistics; it’s about taking a step forward without knowing what lies ahead. HMG offers familiarity woven with decades of research, making it easier for families to trust both the process and their healthcare team.

    Guiding Patients Through Choices: The Human Side

    Nobody should have to navigate the maze of fertility medicine alone. In all my years talking to patients and clinicians, clear, honest counseling outstrips technical points every time. HMG may not fly under the same sleek banners as more recent, engineered drugs, but its legacy is built on more than marketing. It’s built on shared victories in hospital clinics and family living rooms the world over.

    Care teams who take the time to explain not just the how, but also the why, tend to see patients who are more engaged, less anxious, and more willing to stick with challenging protocols. HMG’s roots in natural hormone biology help fulfill that need for reassurance, especially for people who feel overwhelmed by a rash of acronyms and charts.

    Final Thoughts on the Place of HMG in Today’s Reproductive Health Landscape

    Looking at the fertility landscape as it stands today, it’s easy to get swept up in promises of breakthroughs and high-tech solutions. Yet HMG’s continued popularity reflects a balance—grounded in nature and proven across a wide range of real-world scenarios. Its affordability, reliability, and trusted dual-action make it a central part of the clinician’s toolkit, whether for stimulating female ovulation or restoring male reproductive function.

    As fertility science keeps moving, there’s a strong case for ongoing investment in both innovative treatments and long-standing, effective options like HMG. Policy makers, providers, and patients must work together to protect access and support safe, evidence-based use. Listening to patient experiences, collecting honest feedback, and never losing sight of the family at the heart of these decisions will keep HMG—and products like it—shaping positive health stories for years to come.